Dulaglutide (brand name Trulicity) is a long-acting GLP-1 receptor agonist approved by the FDA in 2014 for adults with type 2 diabetes, and later for cardiovascular risk reduction in people with established or high cardiovascular risk
Some of these have stronger clinical support than others
Glutathionylated IL-1 sRII was identified in the redox secretome of unstimulated and LPS-treated THP-1 cells
Contrary to outdated recommendations that advised restricting protein due to concerns about Hepatic encephalopathy, multiple studies have shown that daily protein intake in the range of 1.21.5 g/kg does not increase the risk of hepatic encephalopathy and may, in fact, improve outcomes such as nitrogen balance, muscle preservation, and quality of life [5, 17,18,19,20]
Bupropion (Wellbutrin) isnt better than an SSRIits just different